首页> 外文期刊>Analytical chemistry >Detection of Infantile Batten Disease by Tandem Mass Spectrometry Assay of PPT1 Enzyme Activity in Dried Blood Spots
【24h】

Detection of Infantile Batten Disease by Tandem Mass Spectrometry Assay of PPT1 Enzyme Activity in Dried Blood Spots

机译:干燥血斑中PPT1酶活性的串联质谱法检测婴儿压力疾病

获取原文
获取原文并翻译 | 示例
       

摘要

A new tandem mass spectrometry (MS/MS)-based approach for measurement of the enzymatic activity of palmitoyl protein thioesterase I (PPT1) in dried blood spots (DBS) is presented. Deficiency in this enzyme leads to infantile neuronal ceroid lipofuscinosis (INCL, Infantile Batten disease, CLN1). The assay could distinguish between 80 healthy newborns and three previously diagnosed INCL patients. Unlike the fluorimetric PPT1 assay, the MS/MS assay does not require recombinant beta-glucosidase. Furthermore, the assay could be easily combined with a TPP1 enzyme assay (for CLN2 disease) and can be potentially multiplexed with a large panel of additional lysosomal enzyme assays by MS/MS for newborn screening and postscreening analysis.
机译:提出了一种新的串联质谱(MS / MS),用于测量干燥血斑(DBS)中Palmitoyl蛋白硫代酯酶I(PPT1)的酶促活性的方法。 这种酶的缺乏导致婴儿神经元曲线唇脓性(包括常规,婴儿牛肉疾病,CLN1)。 测定可以区分80个健康的新生儿和3例以前诊断的患者。 与荧光PPT1测定不同,MS / MS测定不需要重组β-葡糖苷酶。 此外,可以容易地将测定与TPP1酶测定(用于CLN2疾病)容易地组合,并且可以通过MS / MS的MS / MS进行大面板的其他溶酶体酶测定来与新生儿筛选和后筛选分析一起复用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号